An update on cardiac troponins as circulating biomarkers in heart failure

被引：19

作者：

Masson S. ^{[1
]}

Latini R. ^{[1
]}

Anand I.S. ^{[2
]}

机构：

[1] Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milan 20156

[2] VA Medical Center, University of Minnesota Medical School, Minneapolis, MN 55417

来源：

Current Heart Failure Reports | 2010年 / 7卷 / 1期

关键词：

Biomarkers; Heart failure; Prognosis; Troponin;

D O I：

10.1007/s11897-010-0001-0

中图分类号：

学科分类号：

摘要：

Circulating troponins and natriuretic peptides are the only biomarkers specifically released from cardiac myocytes that can be determined with robust and sensitive analytical methods, even in healthy subjects. These intracellular proteins are released from reversibly or irreversibly damaged cardiac myocytes into the bloodstream by mechanisms that are not entirely clear. The recent introduction of a new generation of highly sensitive assays of cardiac troponin I or T has not only improved the early diagnosis of acute myocardial infarction but also suggested that there are several causes for troponin release other than acute coronary syndromes. Circulating troponins are elevated in patients with acute or chronic heart failure and are strongly associated with outcome, independently of natriuretic peptides, the benchmark biomarkers in heart failure. In the absence of further experimental evidences, the pathophysiologic basis for the elevation of circulating cardiac troponins in patients with stable chronic heart failure remains speculative. © 2010 Springer Science+Business Media, LLC.

引用

页码：15 / 21

页数：6

共 46 条

[1]

Thygesen K., Alpert J.S., White H.D., Universal definition of myocardial infarction, Circulation, 116, 22, pp. 2634-2653, (2007)

[2]

Saenger A.K., Jaffe A.S., Requiem for a heavyweight: The demise of creatine kinase-MB, Circulation, 118, pp. 2200-2206, (2008)

[3]

Keller T., Zeller T., Peetz D., Et al., Sensitive troponin i assay in early diagnosis of acute myocardial infarction, N Engl J Med, 361, pp. 868-877, (2009)

[4]

Reichlin T., Hochholzer W., Bassetti S., Et al., Early diagnosis of myocardial infarction with sensitive cardiac troponin assays, N Engl J Med, 361, pp. 858-867, (2009)

[5]

Katus H.A., Giannitsis E., Jaffe A.S., Thygesen K., Higher sensitivity troponin assays: Quo vadis?, Eur Heart J, 30, pp. 127-128, (2009)

[6]

Omland T., De Lemos J.A., Sabatine M.S., Et al., A sensitive cardiac troponin T assay in stable coronary artery disease, N Engl J Med, 361, pp. 2538-2547, (2009)

[7]

Kelley W.E., Januzzi J.L., Christenson R.H., Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure, Clin Chem, 55, pp. 2098-2112, (2009)

[8]

La Vecchia L., Mezzena G., Ometto R., Finocchi G., Bedogni F., Soffiati G., Vincenzi M., Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin, American Journal of Cardiology, 80, 1, pp. 88-90, (1997)

[9]

Missov E., Calzolari C., Pau B., Circulating cardiac troponin i in severe congestive heart failure, Circulation, 96, pp. 2953-2958, (1997)

[10]

Sato Y., Yamada T., Taniguchi R., Et al., Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes, Circulation, 103, pp. 369-374, (2001)

← 1 2 3 4 5 →